Bio Techne Corp (TECH)

May 31, 2025

Wells Fargo Begins Coverage of Bio-Techne (TECH) Stock, Gives PT of $59 - Insider Monkey

May 31, 2025

May 30, 2025

Bio-Techne stock price target cut to $65 by Argus - Investing.com South Africa

May 30, 2025

May 30, 2025

Wells Fargo Initiates Coverage on Bio-Techne (TECH) with Overwei - GuruFocus

May 30, 2025

May 30, 2025

Wells Fargo starts Bio-Techne with Overweight, $59 target By Investing.com - Investing.com Canada

May 30, 2025

May 30, 2025

Demystifying Bio-Techne: Insights From 7 Analyst Reviews - Benzinga

May 30, 2025

May 30, 2025

Wells Fargo Initiates Coverage on Bio-Techne (TECH) with Overweight Rating | TECH Stock News - GuruFocus

May 30, 2025

May 30, 2025

Argus Adjusts Price Target on Bio-Techne to $65 From $90 - marketscreener.com

May 30, 2025

May 30, 2025

Wells Fargo starts Bio-Techne with Overweight, $59 target - Investing.com

May 30, 2025

May 30, 2025

Wells Fargo Initiates Bio-Techne at Overweight With $59 Price Target - marketscreener.com

May 30, 2025

May 30, 2025

Bio-Techne Corporation (TECH): A Bull Case Theory - Insider Monkey

May 30, 2025

May 29, 2025

Bio-Techne Corporation: An Insight Into The Pharmaceutical Market Dynamics & China's Economic & Regulatory Environment! - Smartkarma

May 29, 2025

May 29, 2025

Is Bio-Techne Stock The Right Pick For Your Portfolio Now? - Barchart.com

May 29, 2025

May 29, 2025

Is Bio-Techne Stock the Right Pick for Your Portfolio Now? - Nasdaq

May 29, 2025

May 29, 2025

Bio-Techne Sets Triple Conference Appearance: William Blair, Jefferies, and Goldman Sachs in June - Stock Titan

May 29, 2025

May 29, 2025

Bio-Techne to Present at Investor Conferences - Yahoo Finance

May 29, 2025

May 22, 2025

Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN

May 22, 2025

May 22, 2025

Cetera Investment Advisers Sells 887 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World

May 22, 2025

May 21, 2025

Do Wall Street Analysts Like Bio-Techne Stock? - MSN

May 21, 2025

May 20, 2025

(TECH) Technical Pivots with Risk Controls - news.stocktradersdaily.com

May 20, 2025

May 16, 2025

Bio-Techne (NASDAQ:TECH) Rating Increased to Buy at StockNews.com - Defense World

May 16, 2025

May 15, 2025

Ex-Dividend Reminder: Bio-Techne, First Hawaiian and Affiliated Managers Group - Nasdaq

May 15, 2025

May 14, 2025

Wednesday Sector Laggards: Healthcare, Materials - Nasdaq

May 14, 2025

May 14, 2025

What Makes Bio-Techne Corporation (TECH) a Compelling Addition? - Insider Monkey

May 14, 2025

May 14, 2025

ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) - Quantisnow

May 14, 2025

May 13, 2025

Bio-Techne at BofA Securities 2025: Strategic Growth Amid Challenges By Investing.com - Investing.com Nigeria

May 13, 2025

May 13, 2025

Bio-Techne at BofA Securities 2025: Strategic Growth Amid Challenges - Investing.com

May 13, 2025

May 13, 2025

Transcript : Bio-Techne Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 10 - marketscreener.com

May 13, 2025

May 12, 2025

Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance

May 12, 2025

May 12, 2025

Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 - The Malaysian Reserve

May 12, 2025

May 12, 2025

Bio-Techne to Showcase Next-Generation Solutions for Gene and Ce - GuruFocus

May 12, 2025

May 12, 2025

UBS Group Cuts Bio-Techne (NASDAQ:TECH) Price Target to $70.00 - Defense World

May 12, 2025

May 10, 2025

When the Price of (TECH) Talks, People Listen - news.stocktradersdaily.com

May 10, 2025

May 10, 2025

StockNews.com Downgrades Bio-Techne (NASDAQ:TECH) to Hold - Defense World

May 10, 2025

May 09, 2025

Bio-Techne (TECH) Target Price Lowered to $70 by UBS Analyst | T - GuruFocus

May 09, 2025

May 09, 2025

UBS Adjusts Price Target on Bio-Techne to $70 From $95, Maintains Buy Rating - marketscreener.com

May 09, 2025

May 09, 2025

Bio-Techne outlines 2025 growth drivers with NIH uncertainty and strong Protein Sciences performance - MSN

May 09, 2025

May 09, 2025

Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) - GuruFocus

May 09, 2025

May 08, 2025

Bio-Techne, Kytopen collaborate on integrated cellular engineering workflow - TipRanks

May 08, 2025

May 08, 2025

Bio-Techne (TECH) Target Price Lowered by RBC Capital | TECH Sto - GuruFocus

May 08, 2025

May 08, 2025

Bio-Techne (TECH) Target Price Lowered by RBC Capital | TECH Stock News - GuruFocus

May 08, 2025

May 08, 2025

Benchmark Adjusts Bio-Techne Price Target to $75 From $95 - marketscreener.com

May 08, 2025

May 08, 2025

Bio-Techne (TECH): Benchmark Analyst Lowers Target Price but Maintains Buy Rating | TECH Stock News - GuruFocus

May 08, 2025

May 08, 2025

BIO-TECHNE (TECH): Analyst Maintains Hold Rating, Lowers Price Target | TECH Stock News - GuruFocus

May 08, 2025

May 08, 2025

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference - StreetInsider

May 08, 2025

May 08, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Eng - GuruFocus

May 08, 2025

May 08, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing | TECH Stock News - GuruFocus

May 08, 2025

May 08, 2025

Bio-Techne price target lowered to $63 from $72 at RBC Capital - TipRanks

May 08, 2025

May 08, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing - Stock Titan

May 08, 2025

May 08, 2025

Bio-Techne Corporation (NASDAQ:TECH) Q3 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025

May 08, 2025

Bio-Techne Third Quarter 2025 Earnings: EPS Misses Expectations - simplywall.st

May 08, 2025

May 08, 2025

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference | TECH Stock News - GuruFocus

May 08, 2025